CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Research and Treatment. 2018;50(4):1324-1330.   Published online 2018 January 8    DOI: https://doi.org/10.4143/crt.2017.526

Excel Download

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Cancer Research and Treatment. 2018;50(4):1324-1330   Crossref logo
Link1 Link2 Link3

703 PUBLICATION Phase II multicenter study of capecitabine plus oxaliplatin (XELOX) sequentially followed by capecitabine and irinotecan (XELIRI) in first-line therapy for metastatic colorectal cancer (MCRC)
European Journal of Cancer Supplements. 2005;3(2):199-200   Crossref logo
Link1 Link2

627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study
European Journal of Cancer Supplements. 2005;3(2):177   Crossref logo
Link1 Link2

Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)
Annals of Oncology. 2017;28:v244-v245   Crossref logo
Link1 Link2 Link3

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis
British Journal of Cancer. 2013;109(6):1420-1427   Crossref logo
Link1 Link2 Link3

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
Cancer Chemotherapy and Pharmacology. 2008;62(5):849-855   Crossref logo
Link1 Link2 Link3

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
British Journal of Cancer. 2009;100(11):1720-1724   Crossref logo
Link1 Link2 Link3

707 PUBLICATION Capecitabine, oxaliplatin and irinotecan combination: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study
European Journal of Cancer Supplements. 2005;3(2):200-201   Crossref logo
Link1 Link2

A Prospective Multicenter Phase II Study of Cisplatin and Weekly Docetaxel as First-Line Treatment of Recurrent or Metastatic NAsopharyngeal Cancer (KCSG HN07-01)
Annals of Oncology. 2012;23:xi156   Crossref logo
Link1 Link2

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer
Annals of Oncology. 2007;18(11):1810-1816   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.